Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process. Lori A. Leslie, MD: Hello, and welcome to CURE Expert Connections® ...
Eli Lilly Canada, Inc announced today that Jaypirca® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available ...
Monoclonal B-cell lymphocytosis (MBL) is when you have a high number of identical B cells, under 5,000 per microliter, for at least 3 months. It usually causes no symptoms or need for active treatment ...
The most commonly used staging systems worldwide are Rai and Binet, since both are both simple, inexpensive, and easy to use. Staging systems cannot differentiate individuals who will have progressive ...
Although a single CLL-specific genomic aberration has not been identified, ≥80% of CLL cases do exhibit chromosomal abnormalities. 7 Four common genomic alterations exist and include aberrations on ...
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody The treatment of chronic lymphocytic leukemia ...
Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality A discovery set (one trial, n ...
video: This spinning blue shape is the outer shell (glycoprotein) that shields lymphocytic choriomeningitis virus (LCMV) from immune system attack. And yet new research shows that an antibody (grey) ...
The FDA granted accelerated approval to lisocabtagene maraleucel (liso-cel, Breyanzi) for pretreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), drugmaker Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results